The molecular subtypes of MpBC are basal-like breast cancer with estrogen receptor negativity, progesterone receptor negativity, and human epidermal growth factor receptor 2 (HER2) negativity; and MpBC is more aggressive than triple negative breast cancer (TNBC), having a worse prognosis [12,13,14]. This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.